Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators wish to compare the efficacy and patient tolerability of a preparation consisting of 2L Golytely (PEG + electrolytes) plus 15mg of bisacodyl vs the standard preparation of 4L Golytely. The investigators hypothesize that 2L Golytely with 15mg bisacodyl will show similar bowel cleansing efficacy while offering better tolerability.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 2L Golytely/15mg bisacodyl | Experimental | Subjects will be asked to take 2L Golytely + 15mg bisacodyl for bowel prep the day before colonoscopy. |
|
| Standard bowel prep | Active Comparator | Subject will receive standard bowel prep (4L Golytely) prior to colonoscopy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Standard Bowel Prep | Drug | Subjects will be asked to take 4L of Golytely the day prior to procedure. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Difference in Boston Bowel Preparation Scale & Ottawa Bowel Preparation Scale between the two groups | These are established rating scales to evaluate the quality of bowel prep. The ratings will be compared between the two groups. | 30min |
| Measure | Description | Time Frame |
|---|---|---|
| Difference in the number of participants who develop distress symptoms from bowel prep (and the type) between the two groups | Number of participants who develop distress symptoms from bowel prep, and the type of distress symptoms will be compared between the two groups | 20hours |
| Difference in the absolute number/percentage of participants in the two groups who find the bowel prep experience easy, acceptable, difficult, very difficult, or unable to complete. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robert A. Enns, Dr. | University of British Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Paul's Hospital | Vancouver | British Columbia | V6Z 1Y6 | Canada |
Not provided
| ID | Term |
|---|---|
| C033608 | Golytely |
| D001726 | Bisacodyl |
| ID | Term |
|---|---|
| D003408 | Cresols |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 2L Golytely/bisacodyl | Drug | Subjects will be asked to take 2L Golytely and 15mg bisacodyl the day prior to procedure. |
|
Participants will be asked to rate their bowel prep experience (based on ease of use) on a Likert scale. The number of participants in each level will subsequently be quantified (n, %) and compared between the two groups. |
| 20hours |
| D006844 |
| Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |